par Takimoto, Chris H;Awada, Ahmad 
Référence Cancer chemotherapy and pharmacology, 61, 4, page (535-548)
Publication Publié, 2008-04
Référence Cancer chemotherapy and pharmacology, 61, 4, page (535-548)
Publication Publié, 2008-04
Article révisé par les pairs
| Titre: |
|
| Auteur: | Takimoto, Chris H; Awada, Ahmad |
| Informations sur la publication: | Cancer chemotherapy and pharmacology, 61, 4, page (535-548) |
| Statut de publication: | Publié, 2008-04 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| Mots-clés: | Chemotherapy |
| Combination | |
| Phase I/II clinical trials | |
| Solid tumors | |
| Sorafenib | |
| Targeted agent | |
| MeSH keywords: | Animals |
| Antineoplastic Agents -- adverse effects | |
| Antineoplastic Agents -- pharmacokinetics | |
| Antineoplastic Agents -- pharmacology | |
| Antineoplastic Agents -- toxicity | |
| Antineoplastic Combined Chemotherapy Protocols -- pharmacology | |
| Antineoplastic Combined Chemotherapy Protocols -- toxicity | |
| Benzenesulfonates -- adverse effects | |
| Benzenesulfonates -- pharmacokinetics | |
| Benzenesulfonates -- pharmacology | |
| Benzenesulfonates -- toxicity | |
| Clinical Trials as Topic | |
| Drug Interactions | |
| Humans | |
| Neoplasms -- drug therapy | |
| Pyridines -- adverse effects | |
| Pyridines -- pharmacokinetics | |
| Pyridines -- pharmacology | |
| Pyridines -- toxicity | |
| Note générale: | Journal Article |
| Review | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0344-5704 |
| info:doi/10.1007/s00280-007-0639-9 | |
| info:scp/38049019119 | |
| info:pmid/18026728 |
